Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: interstitial lung disease

2015 ACR/ARHP Annual Meeting: Skin Issues in Rheumatic Diseases Present Challenges

Thomas R. Collins  |  March 15, 2016

SAN FRANCISCO—A 40-year-old woman shows up in the clinic with scarring alopecia, with an area of hyperpigmentation on the rim of her scalp, extending from just behind the temple to behind her ears. An examination with a dermatoscope shows hyperkeratotic follicular plugging. The case—in this example, the discoid form of cutaneous lupus erythematosus (DLE)—is one…

Filed under:ConditionsMeeting ReportsMyositisResearch RheumSystemic Lupus Erythematosus Tagged with:2015 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)dermatitisDermatologydermatomyositisDiagnosisImmunologyLupusResearchRheumatic DiseaseskinSLEsubacute cutaneous lupus erythematosus

What Listening to Lungs Might Teach About Rheumatic Disease

Simon M. Helfgott, MD  |  February 17, 2016

One of your first clinical assignments as a medical student was likely to have been the lung exam. Its key descriptors may still resonate in your mind: inspection, palpation, percussion and auscul­tation. Proudly parading down the hospital corridors, your newly purchased stethoscope snugly tucked inside your lab coat pocket, you carefully place its cold metal…

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:examlungspatient carePulmonaryRheumatic Diseaserheumatologist

2015 ACR/ARHP Annual Meeting: Next Generation Sequencing and Disease Mechanisms

Mary Beth Nierengarten  |  February 17, 2016

SAN FRANCISCO—By harnessing the power of next generation sequencing strategies and combining them with clever statistical strategies and tools, investigators are striving to define causal pathways of and mechanisms underlying complex diseases, such as rheumatoid arthritis, according to Soumya Raychaudhuri, MD, PhD, associate professor, Harvard Medical School, Brigham and Women’s Hospital, Boston, during a session…

Filed under:ConditionsMeeting ReportsResearch RheumTechnology Tagged with:2015 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)geneticnext generation sequencingpathwaysResearchvariant

Listen to the Lungs: An Interview with Dr. Aryeh Fischer on ILD

Richard Quinn  |  January 29, 2016

In a recent interview, Aryeh Fischer, MD, addresses the importance of checking patients with autoimmune diseases for interstitial lung disease, noting that advances in technology and awareness can lead to early detection and affect patient outcomes…

Filed under:Conditions Tagged with:ILDInterstitial Lung Diseaselunglung diseaseSystemic sclerosis

Pattern Recognition Key to Fibrosing Lung Disease Diagnosis

Mary Beth Nierengarten  |  January 19, 2016

SAN FRANCISCO—“Interstitial lung disease is the last bastion of great medicine,” according to Paul Noble, MD, chair, Department of Medicine, director, Women’s Guild Lung Institute, Vera and Paul Guerin Distinguished Chair in Pulmonary Medicine, Cedars-Sinai Medical Center, Los Angeles. Making it great medicine, he said, are the many things still unknown about this disease. In…

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)Diagnosisfibrosing lung diseaseResearchrheumatology

Idiopathic Lung Fibrosis—Check for ANCA

Lara C. Pullen, PhD  |  November 30, 2015

New research recommends that doctors test the sera of patients with idiopathic pulmonary fibrosis for anti-neutrophil cytoplasmic antibodies (ANCA), as well as closely monitor this population for signs of lung vasculitis…

Filed under:ConditionsVasculitis Tagged with:ANCAANCA-Associated VasculitisIdiopathic Lung FibrosislungVasculitis

Rheumatology Case Report: When Moyamoya Disease Mimicks Primary Central Nervous System Vasculitis

Joey Kim, MD, Megha Patel-Banker, MD, Matthew Abramson, MD, Mehwish Bilal, MD, Sanjay Godhwani, MD, Asha Patnaik, MD, Heidi Roppelt, MD, & Qingping Yao, MD  |  November 16, 2015

Case report: A 60-year-old Hispanic male with poorly controlled hypertension was sent from the primary care clinic for evaluation of malignant hypertension with a systolic blood pressure above 200 mmHg. His symptoms at the time of presentation included episodic confusion, worsening vision and an unsteady gait. A head computed tomography (CT) scan showed a subacute…

Filed under:ConditionsVasculitis Tagged with:case reportcentral nervous systemDiagnosismoyamoyapatient carerheumatologyTreatmentVasculitis

T Cell Exhaustion: A New Strategy for Treating Autoimmune Disease

Lara C. Pullen, PhD  |  July 27, 2015

Researchers in the U.K. have discovered that manipulating T cells to exhaustion in a targeted way may lead to new treatments and predictors for various types of autoimmune diseases…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Autoimmune diseaseHepatitis C virusT cell

The ACR’s State-of-the-Art Clinical Symposium: Patients with Scleroderma, Lung Disease May Benefit from Aggressive Therapy

Thomas R. Collins  |  July 14, 2015

CHICAGO—Scleroderma patients with pulmonary arterial hypertension (PAH) might benefit from more aggressive therapy, an expert in the field said in a session on lung involvement in rheumatic diseases at the American College of Rheumatology’s 2015 State-of-the-Art Clinical Symposium in May. Newer trials—the SERAPHIN trial on macitentan, GRIPHON on selexipag, and AMBITION on an ambrisentan/tadalafil combination—show…

Filed under:ConditionsEducation & TrainingMeeting ReportsProfessional TopicsResearch RheumSystemic Sclerosis Tagged with:AC&Rclinical symposiumlung diseasepulmonary arterial hypertensionResearchSclerodermatherapy

COPA Genetic Mutation Identified in Lung Disease, Arthritis

Lara C. Pullen, PhD  |  June 15, 2015

Researchers from California and Texas have identified a new genetic syndrome that is characterized by systemic autoimmune disease of the lung and joints. The syndrome is driven by a genetic variant of a vesicular transport protein and is the first documented association between intracellular transport and autoimmunity. Levi B. Watkin, PhD, postdoctoral fellow at Baylor…

Filed under:ConditionsResearch Rheum Tagged with:Arthritisautoimmunity syndromeCOPAgenetic mutationjointlung diseaseResearch

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 26
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences